The Current Ratio as of September 2024 (TTM) for MediWound Ltd. (MDWD) is 1.65

According to MediWound Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 1.65. This represents a change of -54.56% compared to the average of 3.63 of the last 4 quarters.

MediWound Ltd. (MDWD) Historical Current Ratio (quarterly & annually)

How has MDWD Current Ratio performed in the past?

The mean historical Current Ratio of MediWound Ltd. over the last ten years is 6.42. The current 1.65 Current Ratio has changed 2.47% with respect to the historical average. Over the past ten years (40 quarters), MDWD's Current Ratio was at its highest in in the September 2014 quarter at 26.04. The Current Ratio was at its lowest in in the December 2021 quarter at 1.39.

MediWound Ltd. (MDWD) Current Ratio by Quarter and Year

Discovering the peaks and valleys of MediWound Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

MediWound Ltd. (MDWD) Average Current Ratio

How has MDWD Current Ratio performed in the past?

The current Current Ratio of MediWound Ltd. (MDWD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

MediWound Ltd. (MDWD) Current Ratio vs. Peers

How is MDWD’s Current Ratio compared to its peers?

MediWound Ltd.’s Current Ratio is less than Foghorn Therapeutics Inc. (5.69), less than Eliem Therapeutics, Inc. (60.41), less than Sutro Biopharma, Inc. (3.41), less than Dyadic International, Inc. (5.39), less than Crinetics Pharmaceuticals, Inc. (16.09), less than Inhibrx, Inc. (6.20), less than Merus N.V. (9.97), less than Lyell Immunopharma, Inc. (16.19), less than Kronos Bio, Inc. (8.49), less than Aerovate Therapeutics, Inc. (6.51), less than Keros Therapeutics, Inc. (20.37), less than Syndax Pharmaceuticals, Inc. (10.50), less than Mineralys Therapeutics, Inc. (11.20), less than Replimune Group, Inc. (13.46), less than Ocular Therapeutix, Inc. (16.64), less than Veracyte, Inc. (4.44), less than Avidity Biosciences, Inc. (15.78), less than SpringWorks Therapeutics, Inc. (7.91), less than Monte Rosa Therapeutics, Inc. (6.56), less than Nkarta, Inc. (15.91), less than Generation Bio Co. (7.42), less than Sana Biotechnology, Inc. (5.20),

Build a custom stock screener for MediWound Ltd. (MDWD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MediWound Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

MediWound Ltd. (MDWD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like MediWound Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.